Abbott Laboratories (NYSE:ABT)
| 126.63 BATS BZX Real-Time Price As of 11:00am ET |  -0.09 / -0.07%Today’s Change | 103.13 Today|||52-Week Range 129.70 | +15.65% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 7.7B | 7.8B | 7.5B | 8.0B | |
| Cost of Goods Sold | 2.9B | 2.9B | 2.9B | 3.0B | ||
| Depreciation And Amortization | 813.0M | 763.0M | 753.0M | 751.0M | ||
| Operating Expenses | Gross Income | 4.0B | 4.1B | 3.9B | 4.2B | |
| General Expenses | 2.9B | 2.9B | 3.1B | 3.0B | ||
| Research And Development | 573.0M | 561.0M | 670.0M | 577.0M | ||
| Total Operating Expenses | 6.6B | 6.6B | 6.8B | 6.8B | ||
| Non-Operating Expenses | Operating Income | 1.1B | 1.2B | 759.0M | 1.2B | |
| Extraordinary Charge | -85.0M | -103.0M | -35.0M | -1.0M | ||
| Interest Expense On Debt | 169.0M | 268.0M | 214.0M | 264.0M | ||
| Other Expenses | -108.0M | 108.0M | 99.0M | 155.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 718.0M | 947.0M | 632.0M | 1.1B | |
| Income Taxes | -166.0M | -292.0M | -40.0M | -96.0M | ||
| Discontinued Operations | 11.0M | -1.0M | 0.00 | 0.00 | ||
| Net Income | 559.0M | 649.0M | 668.0M | 1.0B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.8B | 1.8B | 1.8B | 1.8B | |
| Shares To Calculate EPS Diluted | 1.8B | 1.8B | 1.8B | 1.8B | ||
| Earnings Per Share | EPS | $0.32 | $0.37 | $0.38 | $0.56 | |
| EPS Diluted | $0.32 | $0.37 | $0.38 | $0.56 | ||
